These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38682289)

  • 1. Improving platelet function following prophylactic platelet transfusion in patients with hematological malignancies.
    Wu YF; Shen CL; Huang WH; Chu SC; Li CC; Liu CZ; Wang TF
    Int J Lab Hematol; 2024 Aug; 46(4):722-730. PubMed ID: 38682289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional recovery of stored platelets after transfusion.
    Bikker A; Bouman E; Sebastian S; Korporaal SJ; Urbanus RT; Fijnheer R; Boven LA; Roest M
    Transfusion; 2016 May; 56(5):1030-7. PubMed ID: 26935249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect and duration of prophylactic platelet transfusions before insertion of a central venous catheter in patients with bone marrow failure evaluated with point-of-care methods and flow cytometry.
    Kander T; Tanaka KA; Norström E; Persson J; Schött U
    Anesth Analg; 2014 Oct; 119(4):882-890. PubMed ID: 24854870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
    Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
    Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of platelet crossmatch results by Solid Phase Red Cell Adherence Assay (SPRCA) with post-transfusion platelet count increment in adult hemato-oncology patients of a tertiary care oncology centre in India.
    Desai P; Sontakke P; Rajadhyaksha S; Navkudkar A
    Transfus Apher Sci; 2020 Oct; 59(5):102842. PubMed ID: 32586771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function of platelets in apheresis platelet concentrates and in patient blood after transfusion as assessed by Impact-R.
    Horvath M; Eichelberger B; Koren D; Böhm A; Ay C; Jilma B; Panzer S; Jilma-Stohlawetz P
    Transfusion; 2010 May; 50(5):1036-42. PubMed ID: 20051058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of efficacy of low and high dose prophylactic platelet transfusion therapy in thrombocytopenic haemato-oncology patients.
    Dhiman Y; Hans R; Sharma RR; Malhotra P; Marwaha N
    Transfus Apher Sci; 2020 Feb; 59(1):102610. PubMed ID: 31345687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
    Estcourt LJ; Stanworth S; Doree C; Trivella M; Hopewell S; Blanco P; Murphy MF
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010984. PubMed ID: 26505729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
    Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
    Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet function testing to assess effectiveness of platelet transfusion therapy.
    Salama ME; Raman S; Drew MJ; Abdel-Raheem M; Mahmood MN
    Transfus Apher Sci; 2004 Apr; 30(2):93-100. PubMed ID: 15062745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors that influence platelet recovery after transfusion: resolving donor quality from ABO compatibility.
    Jiménez TM; Patel SB; Pineda AA; Tefferi A; Owen WG
    Transfusion; 2003 Mar; 43(3):328-34. PubMed ID: 12675717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
    Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
    Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP.
    Frelinger AL; Grace RF; Gerrits AJ; Berny-Lang MA; Brown T; Carmichael SL; Neufeld EJ; Michelson AD
    Blood; 2015 Aug; 126(7):873-9. PubMed ID: 26138687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OC-08 - Multiple functional defects in platelets from thrombocytopenic cancer patients undergoing chemotherapy.
    Baaten CC; Moenen FC; Henskens YM; Swieringa F; Wetzels R; van Oerle R; Ten Cate H; Beckers EA; Heemskerk JW; van der Meijden PE
    Thromb Res; 2016 Apr; 140 Suppl 1():S171. PubMed ID: 27161680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of cross-match compatible platelets in multi transfused haemato-oncology patients refractory to platelet transfusion.
    Chavan A; Sharma RR; Saikia B; Malhotra P; Prakash S; Hans R; Marwaha N
    Transfus Apher Sci; 2019 Dec; 58(6):102657. PubMed ID: 31706911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of platelet microparticles in vivo.
    Rank A; Nieuwland R; Crispin A; Grützner S; Iberer M; Toth B; Pihusch R
    Platelets; 2011; 22(2):111-6. PubMed ID: 21231854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
    Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
    Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogen-reduced platelets for the prevention of bleeding.
    Estcourt LJ; Malouf R; Hopewell S; Trivella M; Doree C; Stanworth SJ; Murphy MF
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD009072. PubMed ID: 28756627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.